May 23, 2019
New Tiara and Reducer Data Presented in Several Presentations at the EuroPCR 2019 Conference in Paris
May 22, 2019
Neovasc Announces Positive Two-Year Follow-up Safety and Efficacy Data for the Neovasc Reducer(TM) in a Peer Reviewed Article in the International Journal of Cardiology
May 16, 2019
Neovasc Announces Closing of Private Placement of Convertible Debt and Common Shares for Gross Proceeds of US$11.5 Million
May 14, 2019
Neovasc Announces Private Placement of Convertible Debt and Equity for Gross Proceeds of US$11.5 Million
May 09, 2019
Neovasc Announces First Quarter 2019 Financial Results
May 06, 2019
Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer(TM)
May 03, 2019
Neovasc to Announce First Quarter 2019 Financial Results on Thursday, May 9th
Apr 26, 2019
Neovasc Provides Highlights from Annual Conference of the DGK, the German Society of Cardiology; Symposium Generates Growing Support for Reducer
Apr 17, 2019
Neovasc Announces Resolution of Last Remaining Active Litigation
Apr 17, 2019
Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer(TM) Improves Diastolic Function in patients suffering from severe angina
Mar 21, 2019
Neovasc Announces Fourth Quarter and Fiscal Year 2018 Financial Results
Mar 21, 2019
Neovasc Wins German Court Appeal; Announces German Court's Decision to Dismiss CardiAQ's Claim to Co-inventorship of a European Patent for Tiara(TM)
Mar 19, 2019
Reducer Featured in Presentation at American College of Cardiology's Annual Meeting
Mar 15, 2019
Neovasc Announces Closing of $5 Million Public Offering of Common Shares
Mar 14, 2019
Neovasc Completes Successful Quality System Surveillance Audit
Mar 13, 2019
Neovasc to Announce Year Ended December 31, 2018 Financial Results on Thursday, March 21
Mar 13, 2019
Neovasc Announces Pricing of $5 Million Public Offering of Common Shares
Mar 12, 2019
Neovasc Announces Proposed Public Offering of Common Shares
Mar 12, 2019
Neovasc Announces Agreements to Exchange Outstanding Warrants for Shares
Mar 05, 2019
Neovasc Announces Reducer(TM) Implant "Live Case" at the CRT Meeting in Washington, DC